CTLA4 and melanoma: Jiang et al. showed that gene signatures of tumor-associated macrophages (TAMs) and MDSC in melanoma samples were associated with reduced T-cell infiltration and resistance to anti-PD-1 and anti-CTLA-4 therapy [114].